EDMONTON—An Alberta woman in her 50s has died from a rare blood clot disorder after receiving the Oxford-AstraZeneca COVID-19 vaccine. It is the second reported death from vaccine-induced immune thrombotic thrombocytopenia or VITT linked to the AstraZeneca vaccine in Canada. A 54-year-old Quebec woman died last month. Alberta’s chief medical officer of health, Dr. Deena Hinshaw, said in a statement late Tuesday that the fatality is the province’s second VITT case out of more than 253,000 doses of AstraZeneca that have been administered in Alberta to date. Two weeks ago, Alberta announced a man in his 60s had been diagnosed with VITT and was recovering. Hinshaw said while any death is tragic, “it is important to remember that the risks of dying or suffering other severe outcomes from COVID-19 remain far greater than the risk following AstraZeneca vaccine.” She noted the global risk of developing VITT has been estimated at …